BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32297950)

  • 1. Release of promoter-proximal paused Pol II in response to histone deacetylase inhibition.
    Vaid R; Wen J; Mannervik M
    Nucleic Acids Res; 2020 May; 48(9):4877-4890. PubMed ID: 32297950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II.
    Boija A; Mahat DB; Zare A; Holmqvist PH; Philip P; Meyers DJ; Cole PA; Lis JT; Stenberg P; Mannervik M
    Mol Cell; 2017 Nov; 68(3):491-503.e5. PubMed ID: 29056321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation.
    Gates LA; Shi J; Rohira AD; Feng Q; Zhu B; Bedford MT; Sagum CA; Jung SY; Qin J; Tsai MJ; Tsai SY; Li W; Foulds CE; O'Malley BW
    J Biol Chem; 2017 Sep; 292(35):14456-14472. PubMed ID: 28717009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing.
    Etchegaray JP; Zhong L; Li C; Henriques T; Ablondi E; Nakadai T; Van Rechem C; Ferrer C; Ross KN; Choi JE; Samarakkody A; Ji F; Chang A; Sadreyev RI; Ramaswamy S; Nechaev S; Whetstine JR; Roeder RG; Adelman K; Goren A; Mostoslavsky R
    Mol Cell; 2019 Aug; 75(4):683-699.e7. PubMed ID: 31399344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
    To KK; Polgar O; Huff LM; Morisaki K; Bates SE
    Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of histone H3 at Ser10 facilitates RNA polymerase II release from promoter-proximal pausing in Drosophila.
    Ivaldi MS; Karam CS; Corces VG
    Genes Dev; 2007 Nov; 21(21):2818-31. PubMed ID: 17942706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.
    Kapoor-Vazirani P; Kagey JD; Vertino PM
    Mol Cell Biol; 2011 Apr; 31(8):1594-609. PubMed ID: 21321083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
    Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
    Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S; Archer TK
    Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin.
    Nightingale KP; Wellinger RE; Sogo JM; Becker PB
    EMBO J; 1998 May; 17(10):2865-76. PubMed ID: 9582280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.
    Khan DH; Gonzalez C; Cooper C; Sun JM; Chen HY; Healy S; Xu W; Smith KT; Workman JL; Leygue E; Davie JR
    Nucleic Acids Res; 2014 Feb; 42(3):1656-70. PubMed ID: 24234443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity.
    Kinyamu HK; Bennett BD; Bushel PR; Archer TK
    J Biol Chem; 2020 Jan; 295(5):1271-1287. PubMed ID: 31806706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
    Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
    Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Integrator Complex Attenuates Promoter-Proximal Transcription at Protein-Coding Genes.
    Elrod ND; Henriques T; Huang KL; Tatomer DC; Wilusz JE; Wagner EJ; Adelman K
    Mol Cell; 2019 Dec; 76(5):738-752.e7. PubMed ID: 31809743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.
    Simboeck E; Sawicka A; Zupkovitz G; Senese S; Winter S; Dequiedt F; Ogris E; Di Croce L; Chiocca S; Seiser C
    J Biol Chem; 2010 Dec; 285(52):41062-73. PubMed ID: 20952396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes.
    Wang Z; Zang C; Cui K; Schones DE; Barski A; Peng W; Zhao K
    Cell; 2009 Sep; 138(5):1019-31. PubMed ID: 19698979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.